Champions Oncology
CSBR
CSBR
14 hedge funds and large institutions have $15.6M invested in Champions Oncology in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% less capital invested
Capital invested by funds: $16.2M → $15.6M (-$572K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
14
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$509K | |
| 2 | +$158K | |
| 3 | +$4.78K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3K |
Top Sellers
| 1 | -$71.2K | |
| 2 | -$61.5K | |
| 3 | -$59K | |
| 4 |
Millennium Management
New York
|
-$55K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.67K |